Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropinirole and Gabapentin for RLS in Hemodialysis
NCT03708237Phase 2Terminated
- Sponsor
- University of Alberta
- Start
- Feb 2019
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ropinirole, gabapentin in restless legs syndrome (RLS), sponsored by University of Alberta. Started Feb 2019; status: terminated.
02
Drugs
ropinirolegabapentin
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT03708237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03708237.